National Cancer Institute U.S. National Institutes of Health | www.cancer.gov
SPORES Logo - Translational Research, Clinical, Pre-Clinical, Basic, Pre-Clinical SPOREs - Specialized Programs of Research Excellence
Home Organization of the TRP Organ-Specific SPORE Programs Information for the Public Patient Advocate Research Team Information for Applicants Address and Directions SPORE Advances  

NCI Organizational Structure

Within the National Cancer Institute organizational structure, the Translational Research Program (TRP) is in the Division of Cancer Treatment and Diagnosis.


Mission and Function Statement of the Translational Research Program

The mission of the Translational Research Program is to integrate scientific advancements in the understanding of the biology of human cancer with the development of new interventions for the prevention, diagnosis, and treatment of cancer patients or populations at risk for cancer, by fostering broad interdisciplinary investigations that focus on bringing discoveries from the laboratory to the clinic, and coordinating resources of the National Cancer Institute with those of academia, industry, and non-profit organizations/foundations to reduce cancer incidence, morbidity and mortality, to extend survival, and to increase the quality of life of cancer patients.

This is accomplished by:

  1. Planning, advising, coordinating, evaluating, and supporting the Specialized Programs of Research Excellence (SPOREs), which use the P50 grant funding mechanism, to translate novel scientific discoveries from the laboratory and/or population studies to the clinic for testing in humans with cancer, to determine the biological basis for clinical observations, and to use specimens from clinical studies to determine correlations between biomarkers and outcomes in patients.
  2. Encouraging and facilitating collaborations between SPOREs, Cancer Centers, other NCI/NIH funded mechanisms and programs, and outside organizations, to increase cross-fertilization of ideas, leverage resources, reduce duplication, and ensure access of resources to projects and investigators.
  3. Establishing high-quality organ-specific tumor specimen banks to provide research resources for the cancer research community.
  4. Maintaining the Developmental Research Program and Career Development Program of the SPOREs to promote high risk/high payoff projects and to ensure the development of promising researchers new to translational research.
  5. Supporting research in high incidence cancers as well as in rare cancers.
  6. Collaborating with patient advocates who support translational science in cancer.

TRP Organizational Structure

The Translational Research Program has the following internal structure:

Interactive Organizational Chart showing structure of Translational Research Program Email Branch Chief Email Program Director -  Prostate, Bladder, Kidney Cancer Email Program Director - Leukemia, Lymphoma, Myeloma, Lung Cancer Email Program Director - Brain, Overian, Skin Cancer Email Program Director - Breast, Endometrial, Cervical Cancer Go to Gastrointestinal SPOREs page Go to Pancreatic SPOREs page Go to Head and Neck Cancer SPOREs pageGo to Head and Neck Cancer SPOREs pageGo to Prostate SPOREs page Go to Genitourinary SPOREs page Go to Genitourinary SPOREs pageGp to Leukemia SPOREs page Go to Lymphoma SPOREs page Go to Myelmoa SPOREs page Go to Lung Cancer SPOREs pageGo to Brain SPOREs page Go to Skin Cancer SPOREs pageGo to Ovarian SPOREs pageGo to Breast SPOREs page Go to Gynecologic SPOREs page Go to Gynecologic SPOREs page Email Program CoordinatorEmail Program Director - GI, Pancreatic, Head and Neck Cancer

Address & Directions

Updated Spring of 2009



National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov